Top News
-
First Patient Dosed in Phase III Perioperative Study of Cadonilimab (PD-1/CTLA-4) in Colon Cancer
Times Argus 2026-10-10, 17:42HONG KONG, Oct. 10, 2026 /PRNewswire/ --...
-
No steel tables, no coffee, just a cracking masala dosE at this Bengaluru eatery
Hindustan Times 2026-10-10, 11:08Santrupthi Upahara in...
-
A nurse mixes a dose of the measles, mumps and rubella virus vaccine at a ...
Lodi News Sentinel 2026-10-10, 07:35A nurse mixes a dose of the measles, mumps and rubella virus vaccine at a pop-up clinic at the...
-
'Doctor X' delivers satisfying dose of justice with Kim Ji-won at center
Korea Times 2026-10-10, 07:28“Doctor X” took aim at doctors chasing power and personal interests within the hospital, delivering a...
-
Man survives deadly snakebite with 60 doses of antivenom
Gulf News 2026-10-09, 17:42Dubai: A 40-year-old Egyptian man was brought back from the brink of death after a venomous snakebite caused...
-
Public Drug Warning: Multiple high-dose MDMA (ecstasy) tablets circulating in NSW (NSW Ministry of Health)
Public Technologies 2026-10-09, 06:01) 09 October 2026 Content 1 NSW Health is warning the public of multiple high-dose MDMA (ecstasy) tablets in...
-
Hashimoto's and GLP-1 medications: Why losing weight can change the thyroid medication dose you need
The Post-Star 2026-10-09, 02:15Ivologist reports indicate that weight loss from GLP-1 medications can alter thyroid medication doses,...
-
Solu Therapeutics Initiates Dosing in Acute Myeloid Leukemia Cohort of the Ongoing Phase 1 Study of STX-0712 (SHVMS LLC)
Public Technologies 2026-10-09, 01:00) BOSTON, MA, October 8, 2026 - Solu Therapeutics, a biotechnology company pioneering novel therapies to...
-
Systematic Review - Low-Dose Radiation Therapy for Treatment of Osteoarthritis (Health Services Research & Development)
Public Technologies 2026-10-08, 22:00) The text version of this document is not available. You can access the...
-
Christa Pike survived 2 doses of an execution drug. How is that possible?
McAlester News-Capital 2026-10-08, 21:33Christa Pike has regained consciousness...
-
PEAKING: PSYCHEDELICS AND THE PURSUIT OF HAPPINESS takes viewers inside dosing rooms to watch psychedelic healing as it happens
PR Newswire 2026-10-08, 20:22One-of-a-kind documentary follows professional athletes, military veterans, people battling opioid addiction,...
-
Solu Therapeutics Initiates Dosing in Acute Myeloid Leukemia Coho... (Pappas Capital LLC)
Public Technologies 2026-10-08, 19:58) News | 10. 08. 2026 Solu Therapeutics BOSTON, Oct. 08, 2026 -- Solu Therapeutics, a biotechnology company...
-
Cullinan Therapeutics Announces First Patient Dosed in Planned Registrational Phase 2 Study of CLN-049 in ...
The Daily Record - Dunn 2026-10-08, 17:37CAMBRIDGE, Mass., Oct. 08, 2026 (GLOBE NEWSWIRE) -- Cullinan Therapeutics, Inc. (Nasdaq: CGEM; “Cullinan”), a...
-
Five African countries unite to tackle zero-dose children through stronger immunisation systems
Joy Online 2026-10-08, 17:08Five African countries have agreed on concrete measures to strengthen immunisation systems and reduce the...
-
Asahi Kasei Therapeutics Announces First Patient Dosed in Phase 2a Trial of AIC468 for BK ...
Business Wire 2026-10-08, 16:37TOKYO--(BUSINESS WIRE)--Asahi Kasei Therapeutics announced that the first patient has been dosed in a...
-
PureTech Founded Entity Seaport Therapeutics Announces First Patient Dosed in Phase 2a Clinical Trial Evaluating ...
Business Wire 2026-10-08, 16:37BOSTON--(BUSINESS WIRE)--PureTech Founded Entity Seaport Therapeutics Doses First Patient in GlyphAgo Phase 2a...
-
Vaxart Announces Publication of Preclinical Study Demonstrating 100% Protection Against a Lethal Dose of H5N1 ...
Nasdaq Globe Newswire 2026-10-08, 15:40Second-generation oral mucosal vaccine candidate (VXA-H5-02) induced robust cross-neutralizing antibodies,...
-
Solu Therapeutics Initiates Dosing in Acute Myeloid Leukemia Cohort of the Ongoing Phase 1 Study ...
Nasdaq Globe Newswire 2026-10-08, 13:16BOSTON, Oct. 08, 2026 (GLOBE NEWSWIRE) -- Solu Therapeutics, a biotechnology company...
-
Edgewise Therapeutics Doses First Patient in Phase 2 EQUINOX-HFpEF Trial of EDG-15400
PR Newswire 2026-10-08, 13:09– Phase 2 trial evaluating EDG-15400 in adults with symptomatic HFpEF with a LVEF of at least 50% – –...
-
Nuevocor Doses First Patient in SUNBEAM-LMNA Phase 1/2 Trial and Receives FDA Fast Track Designation for NVC-001 in LMNA Dilated Cardiomyopathy
PR Newswire 2026-10-08, 13:08NVC-001 is designed to target the mechanobiological root cause of LMNA dilated cardiomyopathy and has...
-
Low-Dose CT Scans Detect Lung Cancer Early (Winchester Medical Center)
Public Technologies 2026-10-07, 22:56) The text version of this document is not available. You can access...
-
Boehringer Ingelheim's New Quarterable Snap-Tab PREVICOX® (firocoxib) Chewable Tablets Provide Flexible Dosing for Dogs in the U.S.
PR Newswire 2026-10-07, 20:20Now approved by the U.S. Food and Drug Administration, this unique tablet design enables more precise,...